Ledger.Open graph →
SEC Form D · filed September 9, 2019

ANSUN BIOPHARMA, INC

Offering
$100.0M
Sold
$78.4M
Exemption
Rule 506(b)
Industry
Other
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Brian A. Meyer · New York, NYDirectorNina Barton · New York, NYDirectorDon A. Mccarthy · New York, NYDirectorCP Collective Apartments Manager, LLC · Newport Beach, CADirectorPhilip M. Bilden · Palm Beach, FLDirectorCP Collective Depositor, LLC · Newport Beach, CADirectorVadim Khramov · Boca Raton, FLDirectorLarry E. Chachkes · MIAMI BEACH, FLExec · DirectorKaren J. Jakobi · Irvine, CADirectorMikael Havluciyan · San Diego, CAExecAdam I. Gunasekara · New York, NYDirectorSaurabh K. Srivastava · New York, NYDirectorSachin K. Srivastava · New York, NYDirectorThomas Casten · Hinsdale, ILDirectorBill Hermann · Port Angeles, WADirectorBenjamin Maritz · SEATTLE, WADirectorLisa Martensson · Dublin 1, IrelandDirectorJohn Hamrock · Dublin 1, IrelandDirectorKarl Mceneff · Dublin 1, IrelandExec · DirectorMikael Havluciyan · SAN DIEGO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗